262 related articles for article (PubMed ID: 33003440)
1. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin associates with CD44 to promote directional cell migration.
Martín-Villar E; Fernández-Muñoz B; Parsons M; Yurrita MM; Megías D; Pérez-Gómez E; Jones GE; Quintanilla M
Mol Biol Cell; 2010 Dec; 21(24):4387-99. PubMed ID: 20962267
[TBL] [Abstract][Full Text] [Related]
3. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells.
Suzuki M; Kobayashi H; Fujie M; Nishida T; Takigawa M; Kanayama N; Terao T
J Biol Chem; 2002 Mar; 277(10):8022-32. PubMed ID: 11777908
[TBL] [Abstract][Full Text] [Related]
4. Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.
Miwa T; Nagata T; Kojima H; Sekine S; Okumura T
Int J Oncol; 2017 Sep; 51(3):771-780. PubMed ID: 28677740
[TBL] [Abstract][Full Text] [Related]
5. Detection of CD44 splice variants in formalin-fixed, paraffin-embedded specimens of human skin cancer.
Dietrich A; Tanczos E; Vanscheidt W; Schöpf E; Simon JC
J Cutan Pathol; 1997 Jan; 24(1):37-42. PubMed ID: 9027631
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
7. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
8. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression.
Bourguignon LY; Zhu D; Zhu H
Front Biosci; 1998 Jul; 3():d637-49. PubMed ID: 9634539
[TBL] [Abstract][Full Text] [Related]
9. CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway.
Liu YN; Tsai MF; Wu SG; Chang TH; Shih JY
Life Sci; 2024 Jan; 336():122345. PubMed ID: 38092140
[TBL] [Abstract][Full Text] [Related]
10. Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma.
Chew SH; Okazaki Y; Akatsuka S; Wang S; Jiang L; Ohara Y; Ito F; Saya H; Sekido Y; Toyokuni S
Free Radic Biol Med; 2017 May; 106():91-99. PubMed ID: 28185919
[TBL] [Abstract][Full Text] [Related]
11. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
[TBL] [Abstract][Full Text] [Related]
12. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.
Shirure VS; Liu T; Delgadillo LF; Cuckler CM; Tees DF; Benencia F; Goetz DJ; Burdick MM
Am J Physiol Cell Physiol; 2015 Jan; 308(1):C68-78. PubMed ID: 25339657
[TBL] [Abstract][Full Text] [Related]
14. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
16. Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen).
Raman PS; Alves CS; Wirtz D; Konstantopoulos K
Biophys J; 2012 Aug; 103(3):415-423. PubMed ID: 22947857
[TBL] [Abstract][Full Text] [Related]
17. Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen).
Alves CS; Yakovlev S; Medved L; Konstantopoulos K
J Biol Chem; 2009 Jan; 284(2):1177-89. PubMed ID: 19004834
[TBL] [Abstract][Full Text] [Related]
18. Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis.
Bruno S; Fabbi M; Tiso M; Santamaria B; Ghiotto F; Saverino D; Tenca C; Zarcone D; Ferrini S; Ciccone E; Grossi CE
Carcinogenesis; 2000 May; 21(5):893-900. PubMed ID: 10783309
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
20. CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]